Nuclear nanomedicine using Si nanoparticles as safe and effective carriers of 188Re radionuclide for cancer therapy
В. М. Петриев(Institute of Engineering Physics), Andrei V. Kabashin(Lasers, Plasmas et Procédés Photoniques), Gleb Tselikov(Centre National de la Recherche Scientifique), I. N. Zavestovskaya(Institute of Engineering Physics), Alesya Mikhailovskaya(Ministry of Health of the Russian Federation), Ivan V. Zelepukin(Uppsala University), Anton A. Popov(Institute of Engineering Physics), Paras N. Prasad(University at Buffalo, State University of New York), Sergey M. Deyev(Institute of Bioorganic Chemistry), V. Yu. Timoshenko(Lomonosov Moscow State University), С. А. Иванов(Ministry of Health of the Russian Federation), А. Д. Каприн(Peoples' Friendship University of Russia), V. A. Tischenko(Ministry of Health of the Russian Federation)
Cited by 67
Related Papers
Nanoparticle-based drug delivery <i>via</i> RBC-hitchhiking for the inhibition of lung metastases growth
|Nanoscale|2018|180
Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery
|Nature Communications|2024|162
Enhancement of the blood-circulation time and performance of nanomedicines via the forced clearance of erythrocytes
|Nature Biomedical Engineering|2020|146
Fast processes of nanoparticle blood clearance: Comprehensive study
|Journal of Controlled Release|2020|93
Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors
|Advanced Drug Delivery Reviews|2025|89